Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
8 Aug 24
S-8
Registration of securities for employees
8 Aug 24
10-Q
2025 Q1
Quarterly report
7 Aug 24
8-K
PetMeds® Announces Fiscal 2025 First Quarter Financial Results
6 Aug 24
8-K
PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer
5 Aug 24
DEFA14A
Additional proxy soliciting materials
2 Jul 24
DEFA14A
Additional proxy soliciting materials
24 Jun 24
DEF 14A
Definitive proxy
24 Jun 24
8-K
PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors
24 Jun 24
10-K
2024 FY
Annual report
14 Jun 24
8-K
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11 Jun 24
8-K
Departure of Directors or Certain Officers
31 May 24
8-K
PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
20 May 24
8-K
PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President
29 Apr 24
8-K
Results of Operations and Financial Condition
15 Apr 24
10-Q
2024 Q3
Quarterly report
15 Apr 24
10-K/A
2023 FY
Annual report (amended)
15 Apr 24
8-K
PetMeds® Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
15 Feb 24
NT 10-Q
Notice of late quarterly filing
9 Feb 24
8-K
PetMeds® Announces Selected Preliminary Third Quarter Financial Results
8 Feb 24
8-K
Other Events
8 Jan 24
10-Q
2024 Q2
Quarterly report
31 Oct 23
8-K
PetMeds® Announces Its Second Quarter Financial Results
30 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Aug 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Aug 23
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Aug 23
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
4 Aug 23
10-Q
2024 Q1
Quarterly report
2 Aug 23
8-K
PetMeds® Announces Its First Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
31 Jul 23
DEFA14A
Additional proxy soliciting materials
20 Jun 23
DEF 14A
Definitive proxy
20 Jun 23
8-K
Departure of Directors or Certain Officers
20 Jun 23
8-K
Conference Call Transcript
26 May 23
10-K
2023 FY
Annual report
23 May 23
8-K
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
22 May 23
8-K
PetMeds® Appoints Sandra Y. Campos to its Board of Directors
18 May 23
8-K
Regulation FD Disclosure
3 Apr 23
Latest ownership filings
4
Jacqueline Paula Smith
19 Aug 24
4
GIAN FULGONI
9 Aug 24
4
Leah Solivan
9 Aug 24
4
Justin L. Mennen
9 Aug 24
4
DIANA G PURCEL
9 Aug 24
4
Leslie C.G. Campbell
9 Aug 24
SC 13G/A
BlackRock Inc.
8 Jul 24
4
Leah Solivan
2 Jul 24
3
Leah Solivan
2 Jul 24
4
Justin L. Mennen
5 Jun 24
3
Justin L. Mennen
5 Jun 24
4
Christine Chambers
4 Jun 24
4
Christine Chambers
20 May 24
4
Mathew N Hulett
1 May 24
4
Sandra Yvette Campos
1 May 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
SC 13G/A
BlackRock Inc.
25 Jan 24
4
Mark Bradley Moseley JR
12 Dec 23
4
GIAN FULGONI
13 Nov 23
4
Mathew N Hulett
7 Nov 23
4
Christine Chambers
7 Nov 23
4
Jacqueline Paula Smith
16 Aug 23
4
Jacqueline Paula Smith
16 Aug 23
4
Leslie C.G. Campbell
4 Aug 23
4
Sandra Yvette Campos
4 Aug 23
4
GIAN FULGONI
4 Aug 23
4
DIANA G PURCEL
4 Aug 23
SC 13G/A
BlackRock Inc.
7 Jul 23
4
Christine Chambers
20 Jun 23
4
Christine Chambers
12 Jun 23
4
Daniel Job Pingree
24 May 23
4
Mark Bradley Moseley JR
23 May 23
3
Sandra Yvette Campos
22 May 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G/A
ProShare Advisors LLC
26 Jan 23
SC 13G/A
BlackRock Inc.
23 Jan 23
3
Christine Chambers
10 Aug 22
4
Peter Cobb
1 Aug 22
4
Leslie C.G. Campbell
1 Aug 22